These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 19687451)

  • 1. Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis.
    Zivadinov R; Weinstock-Guttman B; Hashmi K; Abdelrahman N; Stosic M; Dwyer M; Hussein S; Durfee J; Ramanathan M
    Neurology; 2009 Aug; 73(7):504-10. PubMed ID: 19687451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smoking and disease progression in multiple sclerosis.
    Healy BC; Ali EN; Guttmann CR; Chitnis T; Glanz BI; Buckle G; Houtchens M; Stazzone L; Moodie J; Berger AM; Duan Y; Bakshi R; Khoury S; Weiner H; Ascherio A
    Arch Neurol; 2009 Jul; 66(7):858-64. PubMed ID: 19597087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis.
    Yeh EA; Weinstock-Guttman B; Ramanathan M; Ramasamy DP; Willis L; Cox JL; Zivadinov R
    Brain; 2009 Dec; 132(Pt 12):3392-400. PubMed ID: 19892770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain MRI lesions and atrophy are associated with employment status in patients with multiple sclerosis.
    Tauhid S; Chu R; Sasane R; Glanz BI; Neema M; Miller JR; Kim G; Signorovitch JE; Healy BC; Chitnis T; Weiner HL; Bakshi R
    J Neurol; 2015 Nov; 262(11):2425-32. PubMed ID: 26205635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of moderate alcohol consumption with clinical and MRI measures in multiple sclerosis.
    Foster M; Zivadinov R; Weinstock-Guttman B; Tamaño-Blanco M; Badgett D; Carl E; Ramanathan M
    J Neuroimmunol; 2012 Feb; 243(1-2):61-8. PubMed ID: 22261546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring disease activity and progression in primary progressive multiple sclerosis using MRI: sub-voxel registration to identify lesion changes and to detect cerebral atrophy.
    Stevenson VL; Smith SM; Matthews PM; Miller DH; Thompson AJ
    J Neurol; 2002 Feb; 249(2):171-7. PubMed ID: 11985382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gray matter atrophy is related to long-term disability in multiple sclerosis.
    Fisniku LK; Chard DT; Jackson JS; Anderson VM; Altmann DR; Miszkiel KA; Thompson AJ; Miller DH
    Ann Neurol; 2008 Sep; 64(3):247-54. PubMed ID: 18570297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain atrophy and lesion load measures over 1 year relate to clinical status after 6 years in patients with clinically isolated syndromes.
    Di Filippo M; Anderson VM; Altmann DR; Swanton JK; Plant GT; Thompson AJ; Miller DH
    J Neurol Neurosurg Psychiatry; 2010 Feb; 81(2):204-8. PubMed ID: 19744964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased tissue damage and lesion volumes in African Americans with multiple sclerosis.
    Weinstock-Guttman B; Ramanathan M; Hashmi K; Abdelrahman N; Hojnacki D; Dwyer MG; Hussein S; Bergsland N; Munschauer FE; Zivadinov R
    Neurology; 2010 Feb; 74(7):538-44. PubMed ID: 20089944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis.
    Kappus N; Weinstock-Guttman B; Hagemeier J; Kennedy C; Melia R; Carl E; Ramasamy DP; Cherneva M; Durfee J; Bergsland N; Dwyer MG; Kolb C; Hojnacki D; Ramanathan M; Zivadinov R
    J Neurol Neurosurg Psychiatry; 2016 Feb; 87(2):181-7. PubMed ID: 25722366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI phenotypes based on cerebral lesions and atrophy in patients with multiple sclerosis.
    Tauhid S; Neema M; Healy BC; Weiner HL; Bakshi R
    J Neurol Sci; 2014 Nov; 346(1-2):250-4. PubMed ID: 25220114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive event-related potentials in multiple sclerosis: Correlation with MRI and neuropsychological findings.
    Kimiskidis VK; Papaliagkas V; Sotirakoglou K; Kouvatsou ZK; Kapina VK; Papadaki E; Tsimourtou V; Masoura E; Kazis DA; Papayiannopoulos S; Geroukis T; Bostanjopoulou S
    Mult Scler Relat Disord; 2016 Nov; 10():192-197. PubMed ID: 27919489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Volumes of brain atrophy and plaques correlated with neurological disability in secondary progressive multiple sclerosis.
    Dastidar P; Heinonen T; Lehtimäki T; Ukkonen M; Peltola J; Erilä T; Laasonen E; Elovaara I
    J Neurol Sci; 1999 May; 165(1):36-42. PubMed ID: 10426145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale.
    Bakshi R; Neema M; Healy BC; Liptak Z; Betensky RA; Buckle GJ; Gauthier SA; Stankiewicz J; Meier D; Egorova S; Arora A; Guss ZD; Glanz B; Khoury SJ; Guttmann CR; Weiner HL
    Arch Neurol; 2008 Nov; 65(11):1449-53. PubMed ID: 19001162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A semiautomated measure of whole-brain atrophy in multiple sclerosis.
    Bermel RA; Sharma J; Tjoa CW; Puli SR; Bakshi R
    J Neurol Sci; 2003 Apr; 208(1-2):57-65. PubMed ID: 12639726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study.
    Jacobsen C; Hagemeier J; Myhr KM; Nyland H; Lode K; Bergsland N; Ramasamy DP; Dalaker TO; Larsen JP; Farbu E; Zivadinov R
    J Neurol Neurosurg Psychiatry; 2014 Oct; 85(10):1109-15. PubMed ID: 24554101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial MRI in multiple sclerosis: a prospective pilot study of lesion load, whole brain volume and thalamic atrophy.
    Taylor I; Butzkueven H; Litewka L; MacGregor LR; Szoeke C; Cook M; Mitchell P; Kilpatrick TJ; Tubridy N
    J Clin Neurosci; 2004 Feb; 11(2):153-8. PubMed ID: 14732374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Serum Neurofilament Light Levels With Long-term Brain Atrophy in Patients With a First Multiple Sclerosis Episode.
    Plavina T; Singh CM; Sangurdekar D; de Moor C; Engle B; Gafson A; Goyal J; Fisher E; Szak S; Kinkel RP; Sandrock AW; Su R; Kieseier BC; Rudick RA
    JAMA Netw Open; 2020 Nov; 3(11):e2016278. PubMed ID: 33151313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.
    Rudick RA; Lee JC; Nakamura K; Fisher E
    J Neurol Sci; 2009 Jul; 282(1-2):106-11. PubMed ID: 19100997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.